|
News
Articles Related to ADHD &
Learning Disabilities
Behavioral
Intervention Decreases Need For
Medication In AD/HD Children:
Various treatment interventions
including stimulants
(methylphenidate (MPH):
Ritalin) and parent training
have proven successful in
achieving short-term reduction
in the symptoms of attention
deficit/hyperactive disorder
(AD/HD) in children. A new
study suggests that intensive
behavioral therapy may result
in lower levels of medication
being prescribed by physicians.
- Doctor's Guide
AD/HD
A Major Factor In Tic Disorder:
Individuals with Tourette
syndrome (a severe form of tic
disorder) who are referred for
clinical care also frequently
suffer from attention
deficit/hyperactivity disorder
(AD/HD). A new study suggests
that AD/HD may, in fact,
account for much of the
impairment seen in patients
with tic disorder.
- Doctor's Guide
Concerta
May Provide Once-Daily
Treatment For ADD/ADHD: ALZA
Corporation and Crescendo
Pharmaceuticals Corporation
today announced the first
presentation of pivotal
clinical results of Oros®
methylphenidate, which ALZA has
named Concerta™
(methylphenidate HCl)
extended-release tablets.
- - Doctor's Guide
Attenade
Effective In the Treatment Of
ADD And ADHD: Initial
results of two pivotal efficacy
trials for Celgene Corp.’s
Attenade(TM)
(d-methylphenidate), its
chirally-pure version of
Ritalin(R)
(dl-methylphenidate), for the
treatment of attention deficit
disorder (ADD) and attention
deficit hyperactivity disorder
(ADHD), show that Attenade is
superior to placebo in
controlling the symptoms of the
disorders.
- Doctor's Guide
Researchers
hunt for genetic clues: Technology,
in particular the ability to
study the brain closely, is
leading the way to the genetic
understanding of ADD. New
techniques give a
three-dimensional look at the
functioning of the brain - a
far more detailed look than
magnetic resonance imaging (MRI)
or computerized axial
tomography (CAT) scans provide.
The new technique, called SPECT
for Single Photon Emission
Computer Tomography, shows as
holes the places where the
brain is not functioning - the
right prefrontal lobe, the
basal ganglia and the
like. The research now is
focused on genetic defects
having to do with the brain
chemical dopamine, a
neurotransmitter that conveys
messages from one nerve cell,
or neuron, to another.
Parkinson's disease is another
disorder associated with
dopamine problems. - Arizona
Republic - 9/16
top
| news
research | continued
| support
organizations | index
home
| about
me | general
add info | treatments-medications
| learning
issues
parenting
| news-research
| online
store | email
me
|
